22 results
8-K
EX-10.2
BDTX
Black Diamond Therapeutics Inc
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
that (a) relate to the business of the Company or its subsidiaries or other affiliates or any customer of, supplier to or business partner of the Company
DEF 14A
BDTX
Black Diamond Therapeutics Inc
27 Apr 21
Definitive proxy
4:06pm
concern anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier or other interested party
10-Q
t0ds2ri do
12 May 20
Quarterly report
7:34am
10-K
3b4x1w6
24 Mar 20
Annual report
7:47am
424B4
huc519f
30 Jan 20
Prospectus supplement with pricing info
4:43pm
S-1/A
z4v66q
21 Jan 20
IPO registration (amended)
8:24am
S-1/A
EX-1.1
tad5k 3bfmx7bel
21 Jan 20
IPO registration (amended)
8:24am
S-1
EX-10.8
ugpnsq
3 Jan 20
IPO registration
3:23pm
S-1
u77cqdfs oesz
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.7
qqe uep9wyx
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.10
vn82uk5pomd1m
3 Jan 20
IPO registration
3:23pm
S-1
EX-10.9
u4ugwuy3mu763ubifn5
3 Jan 20
IPO registration
3:23pm
DRS/A
o67x3mqhhnd1tjnw1j00
13 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
nj9m00fwmfnfo oabb5
30 Oct 19
Draft registration statement (amended)
12:00am